Search

Anna Maddock Gooch

from Salt Lake City, UT
Age ~60
Get Report
Also known as:
Anna M Gooch, Willis M Gooch, Anna Louise Gooch, Anna L Gooch, Willis Anna Gooch, Willis Dr Gooch, Anna L Maddock, Anna Murdock, Ann Gooch, Am Gooch
Phone and address:
2515 Beacon Dr, Salt Lake City, UT 84108
(801) 582-2982
Related to:
Christy C Kunin, 62Jake Kunin, 28Chris CornellMichelle Cornell, 34Sidney Smith, 55
Connected to:
Andre Gooch, 37Bryce D Gooch, 42Callie N Gooch, 47Cathy A Gooch, 70Coty D Gooch, 33Darnell Gooch, 62Dock Gooch, 76Eric W Gooch, 42Erika M Gooch, 71Eugene D Gooch, 79

Anna Gooch Phones & Addresses

  • 2515 Beacon Dr, Salt Lake City, UT 84108 (801) 582-2982
  • 1917 1500 E, Salt Lake City, UT 84105 (801) 466-3162 (801) 486-8547
  • Salt Lake Cty, UT
  • Redding, CT
  • Midvale, UT

Business Records

Name / Title
Company / Classification
Phones & Addresses
Anna Gooch
Mbr
Symbiocelltech, LLC
Commercial Physical Research
615 Arapeen Dr, Salt Lake City, UT 84108

Publications

Us Patents

Neo-Islets Comprising Stem And Islet Cells And Treatment Of Diabetes Mellitus Therewith

View page
US Patent:
20230033991, Feb 2, 2023
Filed:
Sep 22, 2022
Appl. No.:
17/934263
Inventors:
- Salt Lake City UT, US
Anna Gooch - Salt Lake City UT, US
Ping Zhang - Salt Lake City UT, US
Zhuma Hu - Salt Lake City UT, US
International Classification:
C12N 5/071
A61K 35/39
A61K 45/06
A61K 31/436
C12N 5/00
A61K 35/35
A61K 9/00
Abstract:
Described are Neo-Islets comprising: a) dedifferentiated islet cells and mesenchymal and/or adipose stem cells; or b) redifferentiated islet cells and mesenchymal and/or adipose stem cells where the cells have been treated so as to facilitate redifferentiation. Further described herein are methods of generating Neo-Islets, the methods comprising: culturing a) dedifferentiated islet cells and mesenchymal and/or adipose stem cells; or b) redifferentiated islet cells and mesenchymal and/or adipose stem cells; on a surface that promotes the formation of cell clusters. Also described are methods of treating a subject, the methods comprising: providing to the subject Neo-Islets described herein. Additionally described are methods of treating a subject suffering from Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, and other types of insulin-dependent diabetes mellitus, or impaired glucose tolerance by providing to the subject Neo-Islet as described herein. Additionally described are methods of treatment in which intraperitoneal administration of islet-sized Neo-Islets composed of high numbers of mesenchymal stem cells and cultured islet cells, durably and reversibly treats, without hypoglycemia, both streptozotocin-induced and spontaneous Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, and other types of insulin-dependent diabetes mellitus, or impaired glucose tolerance.

Adaptation Of Hollow-Fiber-Based Cell Culture Technology For The Manufacturing Of (1) Neo-Islets, Employed For The Treatment Of Type 1 And Type 2 Diabetes Mellitus, And (2) The Generation Of Exosomes From Various Cell Types, Used In The Treatment Of Different Organ Injuries And Diseases

View page
US Patent:
20200208115, Jul 2, 2020
Filed:
Sep 7, 2018
Appl. No.:
16/646112
Inventors:
- Salt Lake City UT, US
Anna L. Gooch - Salt Lake City UT, US
International Classification:
C12N 5/0775
C12M 1/00
C12N 5/071
A61P 3/10
Abstract:
Disclosed herein is a method of generating exosomes (extracellular nanovesicles) and/or neo-islets from mesenchymal or adipose stem cells or islets, or other cells in a Hollow-Fiber-based Cell Expansion (HFCE) System. Such exosomes and/or neo-islets may be used for the treatment of T1DM, T2DM, or associated microvascular disease.

Neo-Islets Comprising Stem And Islet Cells And Treatment Of Diabetes Mellitus Therewith

View page
US Patent:
20170073641, Mar 16, 2017
Filed:
Sep 9, 2016
Appl. No.:
15/261750
Inventors:
- Salt Lake City UT, US
Anna Gooch - Salt Lake City UT, US
Ping Zhang - Salt Lake City UT, US
Zhuma Hu - Salt Lake City UT, US
Assignee:
SymbioCellTech, LLC - Salt Lake City UT
International Classification:
C12N 5/071
A61K 35/39
A61K 35/35
A61K 9/00
A61K 31/436
C12N 5/00
A61K 45/06
Abstract:
Described are Neo-Islets comprising: a) dedifferentiated islet cells and mesenchymal and/or adipose stem cells; or b) redifferentiated islet cells and mesenchymal and/or adipose stem cells where the cells have been treated so as to facilitate redifferentiation. Further described herein are methods of generating Neo-Islets, the methods comprising: culturing a) dedifferentiated islet cells and mesenchymal and/or adipose stem cells; or b) redifferentiated islet cells and mesenchymal and/or adipose stem cells; on a surface that promotes the formation of cell clusters. Also described are methods of treating a subject, the methods comprising: providing to the subject Neo-Islets described herein. Additionally described are methods of treating a subject suffering from Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, and other types of insulin-dependent diabetes mellitus, or impaired glucose tolerance by providing to the subject Neo-Islet as described herein. Additionally described are methods of treatment in which intraperitoneal administration of islet-sized Neo-Islets composed of high numbers of mesenchymal stem cells and cultured islet cells, durably and reversibly treats, without hypoglycemia, both streptozotocin-induced and spontaneous Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, and other types of insulin-dependent diabetes mellitus, or impaired glucose tolerance.
Control profile
Anna Maddock Gooch from Salt Lake City, UT, age ~60 Get Report